Core Viewpoint - Modern Health Technology (00919) reported a revenue of HKD 223 million for the six months ending September 30, 2025, representing a year-on-year decrease of 0.7% [1] Financial Performance - The company's profit attributable to equity shareholders was HKD 6.544 million, a significant improvement from a loss of HKD 16.302 million in the same period last year [1] - Basic earnings per share were HKD 0.072 [1] Revenue Breakdown - The group's revenue primarily comes from beauty, facial care, and body slimming services, with beauty and facial care service revenue decreasing by 5.2% compared to the same period last year [1] - Revenue from body slimming services saw a slight decrease of approximately 0.3% compared to 2024 [1] - Revenue from spa bathing and massage services increased by 28.6% during the review period [1] - Product revenue increased by 30.0% compared to the same period last year [1]

Group 1 - The core viewpoint of the article is that Modern Health Technology (00919.HK) reported a slight decrease in revenue but achieved a net profit compared to a loss in the previous year [1] - For the six months ending September 30, 2025, the group's revenue decreased by 0.7% to HKD 223 million [1] - The net profit for the period was approximately HKD 6.946 million, contrasting with a net loss of HKD 16.125 million in the same period last year [1] Group 2 - The earnings per share for the period were HKD 0.72, while the previous year's earnings per share reflected a loss of HKD 1.80 [1] - The company did not declare or pay any dividends for the six months ending September 30, 2025, and 2024 [1] - The company aims to expand its business at the appropriate time to achieve long-term value and maximize returns for shareholders [1]

Financial Performance - Revenue for the six months ended September 30, 2025, was HKD 222,674,000, a decrease of 0.26% from HKD 224,248,000 in the same period of 2024[3] - Operating profit for the same period was HKD 8,594,000, compared to an operating loss of HKD 10,068,000 in 2024[4] - Net profit for the six months was HKD 6,946,000, a significant recovery from a net loss of HKD 16,125,000 in the previous year[7] - Basic and diluted earnings per share for the period were HKD 0.72, compared to a loss per share of HKD 1.80 in 2024[4] - Total comprehensive income for the period was HKD 8,547,000, compared to a total comprehensive loss of HKD 14,060,000 in the same period last year[6] - The pre-tax profit for the six months ended September 30, 2025, was HKD 6,544,000, compared to a loss of HKD 16,302,000 for the same period in 2024[30] Assets and Liabilities - Non-current assets as of September 30, 2025, amounted to HKD 190,027,000, down from HKD 198,393,000 as of March 31, 2025[8] - Current assets totaled HKD 371,770,000, an increase from HKD 366,066,000 in the previous period[8] - Total liabilities decreased to HKD 328,130,000 from HKD 352,290,000, indicating improved financial stability[9] - The company's equity increased to HKD 199,746,000 as of September 30, 2025, compared to HKD 191,199,000 at the end of March 2025[9] - Total assets as of September 30, 2025, were HKD 561.797 million, slightly down from HKD 564.459 million as of March 31, 2025[19] - The group’s total liabilities decreased to HKD 362.051 million as of September 30, 2025, from HKD 373.260 million as of March 31, 2025[19] Revenue Breakdown - Revenue from beauty and wellness services and sales of skincare and wellness products amounted to HKD 222,674,000 for the six months ended September 30, 2025, compared to HKD 224,248,000 for the same period in 2024, representing a decrease of 0.7%[24] - Revenue from beauty package expiration recognition was HKD 202,668,000, while sales of skincare and wellness products increased to HKD 20,006,000 from HKD 15,386,000, showing a growth of 30.5%[24] - Revenue for beauty and facial care services decreased by 5.2% to HKD 149,697,000 compared to HKD 157,891,000 in the same period last year[44] - Spa and massage revenue increased by 28.6% to HKD 9,502,000, up from HKD 7,391,000 year-on-year[44] - Product sales revenue rose by 30.0% to HKD 20,006,000, compared to HKD 15,386,000 in the previous year[44] Expenses and Costs - Employee benefits expenses decreased by 11.3% to HKD 131,325,000 from HKD 148,071,000 year-on-year, with total employees down by 6.9% to 791[46] - Advertising expenses decreased to HKD 839,000 from HKD 1,031,000 year-on-year, representing 0.4% of revenue[48] - The group incurred other income of HKD 5.590 million for the six months ended September 30, 2025, down from HKD 6.621 million in the same period of 2024[18] - Interest income for the six months ended September 30, 2025, was HKD 1.740 million, compared to HKD 2.161 million for the same period in 2024[18] - The group’s unallocated costs for the six months ended September 30, 2025, were HKD 13.925 million, slightly down from HKD 14.297 million in the same period of 2024[18] Strategic Initiatives - The company plans to continue expanding its beauty and wellness services, focusing on enhancing customer experience and product offerings in the upcoming fiscal year[22] - A strategic plan to integrate artificial intelligence into operations is underway, focusing on automating administrative and inventory management tasks to enhance accuracy and free up human resources for value-added activities[62] - The introduction of AI tools, such as chatbots and personalized recommendation systems, is expected to improve customer experience by providing instant support and tailored product suggestions[62] - The group aims to leverage the current macroeconomic trend of declining retail rents to negotiate better lease terms, potentially significantly reducing rental costs, which are a major operational expense[61] Governance and Compliance - The company adheres to good corporate governance principles to achieve stable management and enhance shareholder value[65] - The board of directors has established various committees, including the remuneration committee, nomination committee, and audit committee, to ensure effective governance[69][70][72][73] - The audit committee has reviewed and approved the group's financial statements for the review period[73] - The group regularly reviews its compensation policies to ensure compliance with legal regulations and market standards[58] Future Outlook - The group has a strong brand presence and customer base, contributing to management's confidence in future growth prospects[38] - The mid-term report will be published on December 23, 2025, or around that date, and will be available on the Hong Kong Stock Exchange website and the company's website[75]

Core Viewpoint - Modern Health Technology (00919) anticipates a profit of no less than HKD 5 million for the six months ending September 30, 2025, compared to a loss of approximately HKD 16 million during the same period last year, indicating a significant turnaround in financial performance [1] Financial Performance - The expected shift from loss to profit is primarily attributed to the company's implementation of lean management practices, which have led to a reduction in labor costs during the period [1]

Core Viewpoint - Modern Health Technology (00919) expects to achieve a profit of no less than 5 million HKD for the six months ending September 30, 2025, a significant turnaround from a loss of approximately 16 million HKD in the same period last year, primarily due to enhanced operational efficiency and reduced labor costs [1] Financial Performance - The company anticipates a profit of at least 5 million HKD for the upcoming six-month period [1] - In the previous year, the company reported a loss of around 16 million HKD for the same period [1] Operational Efficiency - The expected turnaround from loss to profit is attributed to the company's deepened lean management practices [1] - The implementation of these practices has led to a reduction in labor costs during the specified period [1]

Core Viewpoint - Modern Health Technology (00919.HK) expects to report a profit of at least HKD 5 million for the six months ending September 30, 2025, compared to a loss of approximately HKD 16 million in the same period last year, primarily due to enhanced operational efficiency and reduced labor costs [1] Financial Performance - The company anticipates a significant turnaround from a loss of HKD 16 million to a profit of at least HKD 5 million [1] - The expected profit indicates a positive shift in financial performance, reflecting effective management strategies [1] Operational Efficiency - The improvement in profitability is attributed to the implementation of lean management practices, which have led to a reduction in labor costs [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不會就因本公佈全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED （現 代 健 康 科 技 控 股 有 限 公 司） （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） 本公司目前仍在編製本集團截至二零二五年九月三十日止六個月之中期業績。本 公佈所載資料僅根據董事會經參考須待本公司及其核數師適當調整及進一步審閱 的本集團截至二零二五年九月三十日止六個月未經審核財務資料作出之初步評估 而作出。股東及有意投資者務請細閱本集團截至二零二五年九月三十日止六個月 之中期業績公佈，以瞭解更多詳情，該公佈預期將於二零二五年十一月底前刊發。 – 1 – （股 份 代 號：919） 正面盈利預告 本公佈乃由現代健康科技控股有限公司（「本公司」，連同其附屬公司，「本集團」） 根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條以及香港法 例第571章證券及期貨條例第XI ...

格隆汇11月7日丨现代健康科技(00919.HK)公告，公司将于2025年11月28日(星期五)在香港举行董事会会 议，以(其中包括)批准刊发公司及其附属公司截至2025年9月30日止6个月中期业绩及考虑派发中期股息 (如有)。 ...

（股 份 代 號：919） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不會就因本公佈全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 MODERN HEALTHCARE TECHNOLOGY HOLDINGS LIMITED （現 代 健 康 科 技 控 股 有 限 公 司） （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） 董事會會議通知 現代健康科技控股有限公司（「本公司」）之董事會（「董事會」）欣然宣佈，本公司將 於二零二五年十一月二十八日（星期五）在香港舉行董事會會議，以（其中包括）批 准刊發本公司及其附屬公司截至二零二五年九月三十日止六個月之中期業績及考 慮派發中期股息（如有）。 承董事會命 現代健康科技控股有限公司 執行董事 曾裕 於本公佈日期，董事會由三名執行董事曾裕博士、葉啟榮先生及楊詩敏女士；以 及四名獨立非執行董事廖美玲女士、黃文顯博士、康寶駒先生及林德亮先生組成。 香港，二零二五年十一月七日 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代健康科技控股有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00919 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | HKD | | 0 | | 本月底結存 | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | 本月底法定/註冊股 ...